ArticleEuropean heart journal. Imaging methods and practice2026
Fully automated deep learning MAPSE: retrospective analysis and real-time clinical application.
Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Mitral annular plane systolic excursion (MAPSE) is an accessible echocardiographic measure of left ventricular (LV) function. However, manual measurement methods are operator-dependent and time-consuming. We developed a multistep deep learning (DL) method for off-line and real-time fully automated MAPSE estimation, and aimed to assess agreement, reproducibility, time efficiency, and feasibility compared with standard manual measurements. Methods and results: The DL-based method was evaluated in two retrospective cohorts ( Conclusion: This novel DL method for fully automated MAPSE demonstrated excellent feasibility, robust reproducibility, and good agreement with both manual M-mode and CMR-derived measurements. Automated DL-MAPSE could substantially reduce analysis time and enhance reproducibility, increasing its clinical value as a marker of LV systolic function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.